| DC Field | Value | Language |
|---|
| dc.contributor.author | Чебан, К. | |
| dc.date.accessioned | 2020-03-25T00:23:04Z | |
| dc.date.available | 2020-03-25T00:23:04Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | Чебан, К. Эффективность глазных капель Офтаквикс в лечении язв роговицы. In: Curierul Medical. 2010, nr. 1(313), pp. 43-45. ISSN 1875-0666. | en_US |
| dc.identifier.issn | 1875-0666 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/7956 | |
| dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2016/09/2.pdf | |
| dc.description | Кафедра Офтальмологии, ГУМФ им. Н. А. Тестемицану | en_US |
| dc.description.abstract | The aim of the study was to determine the therapuetical efficacy of the new ophtalmological drug Oftaquix (levofloxacin 0.5%) in the treatment
of corneal ulcers and inflammatory processes as compared with the results of basic therapy. The study included 72 patients who were divided in
two groups: the main group, which included 40 patients with corneal ulcers who took Oftaquix in addition to the basic therapy, and the control
group - 32 patients who were given only the basic therapy. The study showed the ophthalmologic drops Oftaquix when supplementing the basic
therapy produced a more rapid resolution of the corneal ulcer, significantly diminished the concentration of systemic inflammatory cytokines,
and shortened the period of illness in comparison with treatment with the basic therapy alone. | en_US |
| dc.description.abstract | Scopul studiului a fost de a aprecia eficienţa terapeutică a picăturilor oftalmice Oftaquix (levofloxacin 0,5%) în tratamentul proceselor
inflamatorii şi al ulcerelor corneene, în comparaţie cu terapia de bază. Studiul a inclus 72 de bolnavi cu ulcer cornean care au fost divizaţi în
două loturi: lotul de bază (n=40) a administrat Oftaquix asociat la tratamentul de bază, lotul de control, 32 de pacienţi, au făcut doar tratamentul
de bază. S-a fost stabilit că picăturile oftalmice Oftaquix, asociate la tratamentul de bază, determină tratarea mai rapidă a ulcerelor corneene; de
asemenea, diminuează semnificativ concentraţia markerilor inflamaţiei sistemice, în comparaţie cu terapia de bază. | |
| dc.language.iso | ru | en_US |
| dc.publisher | Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” | en_US |
| dc.relation.ispartof | Curierul Medical | |
| dc.subject | oftalmological | en_US |
| dc.subject | Oftaquix | en_US |
| dc.subject | corneal ulcers | en_US |
| dc.subject.mesh | Corneal Ulcer--drug therapy | en_US |
| dc.subject.mesh | Ophthalmic Solutions--therapeutic use | en_US |
| dc.subject.mesh | Oftaquix--therapeutic use | en_US |
| dc.title | Эффективность глазных капель Офтаквикс в лечении язв роговицы | en_US |
| dc.title.alternative | Efficiency of the ophtalmological drops Oftaquix in treatment of corneal ulcers | en_US |
| dc.title.alternative | Eficienţa picăturilor oftalmice Oftaquix în tratamentul ulcerelor corneene | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Curierul Medical, 2010, Vol. 313, Nr. 1
|
